IPO Boutique

Kaleido Biosciences, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Kaleido Biosciences, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Kaleido Biosciences, Inc.KLDO -
NASDAQ
$20.00-$22.00 $15.00 $12.805 million2/28/2019
Goldman Sachs, J.P. Morgan, Morgan Stanley
Co-Manager(s):
Canaccord Genuity
Health Care
Filing(s):

Terms Added 2019-02-19
Filed 2019-01-11
Terms Added 2019-02-19



Kaleido Biosciences, Inc. Quote & Chart - Click for current quote - KLDO

About Kaleido Biosciences, Inc. (adapted from Kaleido Biosciences, Inc. prospectus):
They are a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease and improve human health.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "KLDO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved